Physical Fitness and Physical Function in Patients With Fabry Disease: A Cross‐Sectional Multicentre Study
Open Access
- 18 February 2026
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 17 (1) , e70233
Abstract
Background: Fabry disease (FD) is a rare, X‐linked lysosomal storage disorder affecting multiple organs, including the musculoskeletal system. The physical status of FD patients remains poorly characterized. This multicentre cross‐sectional study aimed to evaluate physical fitness and function in FD patients and investigate associations with sex, FD phenotype and treatment status. Methods: Adults (aged ≥ 18 years) with genetically confirmed FD were recruited. Demographic and laboratory data were collected. Physical fitness was assessed using cardiopulmonary exercise testing (VO 2 peak) and body composition parameters (fat‐free mass index [FFMI], fat mass index [FM] and phase angle [PA]) via bioelectrical impedance analysis. Physical function was evaluated with performance tests (6‐min walk test, handgrip strength test, 30‐s chair‐stand test, short physical performance battery), muscle strength tests (isometric and isokinetic knee strength) and self‐report fatigue questionnaires. Statistical analyses were stratified by sex, phenotype (classic vs. late‐onset/Variants of Uncertain Significance [VUS]) and treatment status (enzyme replacement therapy [ERT]/chaperone‐treated versus untreated). Results: Forty‐two FD patients (13 males; mean age 46 ± 13.9 years) were enrolled. VO 2 < 85% of predicted was more frequent in classic phenotype patients (53.8%) than in late‐onset/VUS (11.5%; p < 0.01). FFMI was lower in classic than late‐onset/VUS (16.8 ± 1.0 vs. 18.6 ± 2.1 kg/m 2 ; p = 0.01). Treated males had lower PA than untreated males (4.8° ± 1.0° vs. 7.6° ± 0.9°; p = 0.04), and PA correlated with VO 2 peak ( r = 0.879; p = 0.01). Among classic phenotype males, 74.3% scored below the 50th percentile in handgrip strength (26.1 ± 7.8 kg), and 60.9% performed below predicted values in the 30‐s chair‐stand test (12.4 ± 4.3 repetitions). Self‐reported fatigue scores were higher in classic versus late‐onset/VUS patients ( p = 0.05) and in treated patients compared to untreated patients ( p = 0.02). Conclusions: Classic FD phenotype, particularly in males, was associated with reduced exercise capacity, muscle mass and physical performance. These findings support the integration of cardiopulmonary exercise testing, physical functional assessments and body composition analysis into the routine evaluation of FD patients.Keywords
Funding Information
- Università degli Studi di Verona
This publication has 40 references indexed in Scilit:
- Educating the Student Body2013
- Fabry diseaseOrphanet Journal of Rare Diseases, 2010
- Global Physical Activity Questionnaire (GPAQ): Nine Country Reliability and Validity StudyJournal of Physical Activity and Health, 2009
- Fabry's diseaseThe Lancet, 2008
- Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry diseaseJournal of Inherited Metabolic Disease, 2006
- Phase Angle From Bioelectrical Impedance Analysis: Population Reference Values by Age, Sex, and Body Mass IndexJournal of Parenteral and Enteral Nutrition, 2006
- Physical Fitness Assessment: An UpdateJournal of Long-Term Effects of Medical Implants, 2006
- Cardiopulmonary Exercise Testing in Fabry DiseaseRespiration, 2005
- ATS/ACCP Statement on Cardiopulmonary Exercise TestingAmerican Journal of Respiratory and Critical Care Medicine, 2003
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002